It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes

March 8, 2010

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced that it filed an application to the Ministry of Health, Labour and Welfare (MHLW) in February 2010, for the addition of myelodysplastic syndromes as a purpose of use for its WT1 mRNA Assay Kit "Otsuka", an in-vitro diagnostic kit.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases